ClinicalMetric / Countries / Greece
← All Countries
🇬🇷
COUNTRY FEED

Clinical Trials in Greece

Active recruiting clinical trials with sites in Greece. Select a condition below to see detailed trial listings.

Total Trials: 50 // Recruiting: 50 // Updated: Daily

Greece currently has 50 clinical trials with at least one registered site in the country, of which 50 are actively recruiting participants. The most studied conditions at Greece sites are Cardiovascular Diseases, Breast Cancer, TAVI, reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including National and Kapodistrian University of Athens, Aristotle University Of Thessaloniki, University of West Attica. By stage, active Greece trials break down as Phase 1 (6), Phase 2 (3), Phase 4 (1). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in Greece

Cardiovascular Diseases 3 Breast Cancer 2 TAVI 2 Obesity 2 Coronary Artery Disease 2 Multiple Sclerosis 2 Opioid-Refractory Chronic Cancer-Related Pain 1 COPD 1 Anesthesia 1 Pain, Postoperative 1 Pain, Chronic 1 Opioid Free Anaesthesia 1 Cancer Recurrence 1 Hereditary Transthyretin Amyloidosis With Polyneuropthy 1 Ischemic Stroke 1 AAT9 1 Systemic Lupus Erythematosus 1 Uveitis 1 Aortic Valve Disease 1 Transcatheter Aortic Valve Implantation 1
All Countries → All Trials →

Other Countries in This Region

🇩🇪Germany 🇫🇷France 🇮🇹Italy 🇪🇸Spain 🇬🇧United Kingdom 🇳🇱Netherlands 🇧🇪Belgium 🇵🇱Poland 🇸🇪Sweden 🇦🇹Austria
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology